Edoxaban in Peripheral Arterial Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

February 6, 2013

Primary Completion Date

December 3, 2014

Study Completion Date

December 3, 2014

Conditions
Peripheral Arterial Disease
Interventions
DRUG

edoxaban

DRUG

Clopidogrel

75mg tablet

DRUG

Aspirin

Trial Locations (42)

Unknown

Birmingham

Phoenix

Beverly Hills

Los Angeles

Orange

New Haven

Hollywood

Jacksonville

Aurora

Iowa City

New Orleans

Lewiston

Boston

Flint

Ypsilanti

Teaneck

New York

Raleigh

Wilmington

Cleveland

Columbus

Camp Hill

Columbia

Greenville

Austin

San Antonio

Graz

Innsbruck

Vienna

Edgem, Edegem

Ghent

Leuven

Bad Krozingen

Leipzig

Afula

Jerusalem

Tel Aviv

Tel Litwinsky

Rotterdam

Utrecht

Bern

Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

lead

Daiichi Sankyo

INDUSTRY